论文部分内容阅读
目的探讨低分子肝素(速避凝)联合疏血通对不稳定性心绞痛患者治疗的疗效。方法不稳定性心绞痛患者138例随机分为2组:治疗组69例,用速避凝5000U,皮下注射,q12h,连用5d;同时用疏血通注射液6ml加入5%葡萄糖250ml静脉滴注,每日1次,连用10d。对照组69例,口服阿司匹林、硝酸异山梨醇酯,静脉滴注硝酸酯类10d。结果治疗组临床总有效率为91.3%,对照组为68.1%,2组比较差异有统计学意义(P<0.01)。治疗组1例发生轻度消化道出血,余2组均无明显不良反应发生。结论低分子肝素联合疏血通治疗不稳定性心绞痛患者疗效好,不良反应少。
Objective To investigate the curative effect of low molecular weight heparin combined with Shuxuetong on patients with unstable angina pectoris. Methods 138 patients with unstable angina pectoris were randomly divided into two groups: the treatment group, 69 cases, with the speed of the avoidance of coagulation 5000U, subcutaneous injection, q12h, once every 5d; at the same time with Shuxuetong injection 6ml 5% glucose 250ml intravenous infusion, 1 day, once every 10d. Control group, 69 cases, oral aspirin, isosorbide dinitrate, intravenous nitrate 10d. Results The total clinical effective rate was 91.3% in the treatment group and 68.1% in the control group. The difference between the two groups was statistically significant (P <0.01). One patient in the treatment group had mild gastrointestinal bleeding, and the other two groups had no obvious adverse reactions. Conclusion Low molecular weight heparin combined with Shuxuetong in patients with unstable angina pectoris has good curative effect and few adverse reactions.